SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001214659-21-001718
Filing Date
2021-02-16
Accepted
2021-02-12 18:42:39
Documents
1
Group Members
ANDREW J. M. SPOKESDAVID T. KIMFARALLON CAPITAL (AM) INVESTORS, L.P.FARALLON CAPITAL F5 MASTER I, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS II, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P.FARALLON CA

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 r211217sc13ga2.htm SC 13G/A 307563
  Complete submission text file 0001214659-21-001718.txt   310273
Mailing Address ONE MARITIME PLAZA SUITE 2100 SAN FRANCISCO CA 94111
Business Address ONE MARITIME PLAZA SUITE 2100 SAN FRANCISCO CA 94111 (415)421-2132
FARALLON CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000909661 (see all company filings)

IRS No.: 943240279 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 11099 N. TORREY PINES ROAD SUITE 100 LA JOLLA CA 92037
Business Address 11099 N. TORREY PINES ROAD SUITE 100 LA JOLLA CA 92037 858-450-4222
DermTech, Inc. (Subject) CIK: 0001651944 (see all company filings)

IRS No.: 842870849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90026 | Film No.: 21630861
SIC: 8071 Services-Medical Laboratories
Office of Life Sciences